torularhodin

02/02/2023 - "Finally, LPS-induced RAW 264.7 cells were used as an inflammation model to assess torularhodin's protective effect on inflammatory cells and to determine whether the TLR4 pathway is associated with this process. "
09/27/2022 - "Torularhodin, as a new food resource, may act as a therapeutic agent to prevent hepatic dyslipidemia and related inflammation for improved health."
09/27/2022 - "Torularhodin Alleviates Hepatic Dyslipidemia and Inflammations in High-Fat Diet-Induced Obese Mice via PPARα Signaling Pathway."
09/27/2022 - "Torularhodin is a β-carotene-like compound from Sporidiobolus pararoseus, and its protective effect against high-fat diet (HFD)-induced hepatic dyslipidemia and inflammation was investigated. "
09/27/2022 - "KEGG signaling pathway analysis revealed that the PPARα signaling pathway is likely fundamental to the health function of Torularhodin through up-regulating genes related to fatty acid β-oxidation, cholesterol excretion, HDL-Cc formation, and anti-inflammation. "

06/17/2020 - "Behavioral and histopathological results suggested that torularhodin relieved cognitive impairments, attenuated Aβ accumulation, and inhibited glial overactivation in d-gal/AlCl3-induced ICR mice. "
06/17/2020 - "Thus, torularhodin effectively ameliorated cognitive impairment, oxidative stress, and neuroinflammation, possibly through the Nrf2/NF-κB signaling pathways, suggesting torularhodin might offer a promising prevention strategy for neurodegenerative diseases."
06/17/2020 - "Torularhodin from Sporidiobolus pararoseus Attenuates d-galactose/AlCl3-Induced Cognitive Impairment, Oxidative Stress, and Neuroinflammation via the Nrf2/NF-κB Pathway."

09/27/2022 - "Torularhodin, as a new food resource, may act as a therapeutic agent to prevent hepatic dyslipidemia and related inflammation for improved health."
09/27/2022 - "Torularhodin Alleviates Hepatic Dyslipidemia and Inflammations in High-Fat Diet-Induced Obese Mice via PPARα Signaling Pathway."
09/27/2022 - "Torularhodin is a β-carotene-like compound from Sporidiobolus pararoseus, and its protective effect against high-fat diet (HFD)-induced hepatic dyslipidemia and inflammation was investigated. "

01/01/2019 - "Moreover, torularhodin was involved in some cellular pathways, such as cancer inhibition, antioxidation, and aging delay. "
12/16/2017 - "Corrigendum to "The suppression of torulene and torularhodin treatment on the growth of PC-3 xenograft prostate tumors" [Biochem. "
01/22/2016 - "The suppression of torulene and torularhodin treatment on the growth of PC-3 xenograft prostate tumors."
01/22/2016 - "These results show that both torulene and torularhodin supplementation inhibit the growth of prostate cancer in nude mice and suggest that such an action is associated the apoptosis of tumor cells."
01/22/2016 - "The present study was to elucidate the anti-cancer activity of torulene and torularhodin in vivo with lycopene as a control. "

01/22/2016 - "Nude mice were orally supplemented every day with a low or high dose [9 or 18 mg/kg body weight (BW)] of lycopene, torularhodin or torulene. "
09/27/2022 - "Compared to mice of C57BL/6J fed on HFD, the addition of Torularhodin into the HFD (HFD-T) significantly reduced body weight, serum triglyceride (TG), total cholesterol (TC), low-density lipoprotein (LDL), and the inflammatory mediators of TNF-α, IL-6, IL-1β, and lipopolysaccharide (LPS). "